Related Experiment Video
Updated: Jul 25, 2026

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
Glycine Substitution Reduces Antimicrobial Activity and Helical Stretch of diPGLa-H in Lipid Micelles
M-A Sani1, C Saenger1, D Juretic2
1School of Chemistry, Bio21 Institute, University of Melbourne , Victoria 3010, Australia.
Abstract:
With the rise in antibiotic resistance, antimicrobial peptides (AMPs) show promise for therapeutic development, but higher specificity is required. PGLa-H is a naturally occurring decapeptide, reported to have moderate antibacterial activity and low hemolytic activity, with its sequence being identical to that of the C-terminal fragment of highly selective AMP, PGLa. DiPGLa-H, a sequential tandem repeat of PGLa-H, and Kiadin, an analogue with a Val to Gly substitution at position 15, display improved in vitro bactericidal activity against both Gram-negative and Gram-positive pathogens, with generally low toxicity for human cells. Despite Gly being a more flexible residue, NMR structural studies showed little difference in structure and dynamics between the two peptides for the first 14 residues, with somewhat greater flexibility in the C-terminus of Kiadin resulting in a tighter structure of the peptide in the presence of sodium dodecyl sulfate micelles. AMPs found in organisms often exhibit minimal amino acid mutations, and such small differences in peptide conformation may be utilized to design more selective AMPs.
Insights
Antimicrobial peptides (AMPs) offer therapeutic potential against antibiotic resistance. Modified peptides like DiPGLa-H and Kiadin show enhanced antibacterial activity with low human cell toxicity, paving the way for selective drug design.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- The increasing threat of antibiotic resistance necessitates novel therapeutic strategies.
- Antimicrobial peptides (AMPs) are a promising class of therapeutics, but their clinical application is limited by the need for improved specificity and reduced toxicity.
- PGLa-H, a decapeptide, exhibits moderate antibacterial and low hemolytic activity, sharing sequence identity with the selective AMP PGLa.
Purpose of the Study:
- To investigate the potential of modified antimicrobial peptides (AMPs) for enhanced therapeutic applications.
- To evaluate the antibacterial efficacy and human cell toxicity of DiPGLa-H and Kiadin, analogues of PGLa-H.
- To elucidate the structural basis for the improved activity and selectivity of these modified AMPs.
Main Methods:
- Synthesis and in vitro testing of DiPGLa-H and Kiadin against Gram-negative and Gram-positive bacteria.
- Assessment of hemolytic activity and general toxicity towards human cells.
- Nuclear Magnetic Resonance (NMR) spectroscopy to study peptide structure and dynamics in the presence of sodium dodecyl sulfate (SDS) micelles.
Main Results:
- DiPGLa-H and Kiadin demonstrated significantly improved in vitro bactericidal activity compared to PGLa-H against a range of pathogens.
- Both modified peptides exhibited generally low toxicity towards human cells, indicating improved selectivity.
- NMR studies revealed minimal structural differences in the N-terminal regions but greater C-terminal flexibility in Kiadin, leading to a tighter structure in micellar environments.
Conclusions:
- Sequential tandem repeats and specific amino acid substitutions (e.g., Val to Gly) can enhance the antibacterial potency and selectivity of AMPs.
- Subtle conformational changes, influenced by amino acid modifications and environmental conditions, are crucial for optimizing AMP function.
- These findings highlight the potential of rational design, based on understanding structure-activity relationships, to develop next-generation antimicrobial peptide therapeutics.
Related Concept Videos
Protein Folding
Detergent Purification of Membrane Proteins
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis

